Advanced search
Publication Cover
Patient Related Outcome Measures Volume 10, 2019 - Issue
Submit an article Journal homepage
129
Views
4
CrossRef citations to date
0
Altmetric
Original Research

The Oxford Participation and Activities Questionnaire (Ox-PAQ): development of a short form and index measure

Crispin JenkinsonHealth Services Research Unit, Nuffield Department of Population Health, University of Oxford, OxfordOX3 7LF, UKCorrespondence[email protected]
,
Laura KellyHealth Services Research Unit, Nuffield Department of Population Health, University of Oxford, OxfordOX3 7LF, UK
,
Sarah DummettHealth Services Research Unit, Nuffield Department of Population Health, University of Oxford, OxfordOX3 7LF, UK
&
David MorleyHealth Services Research Unit, Nuffield Department of Population Health, University of Oxford, OxfordOX3 7LF, UK
Pages 227-232 | Published online: 29 Jul 2019

References

  • World Health Organisation. International Classification of Functioning, Disability and Health. Geneva: World Health Organisation; 2001.
  • Morley D, Dummett S, Kelly L, Dawson J, Fitzpatrick R, Jenkinson C. The Oxford Participation and Activities Questionnaire: study protocol. Patient Relat Outcome Meas. 2014;5:1–6.
  • Kelly L, Jenkinson C, Dummett S, Dawson J, Fitzpatrick R, Morley D. Development of the Oxford Participation and Activities Questionnaire: constructing an item pool. Patient Relat Outcome Meas. 2015;6:145–155. doi:10.2147/PROM.S8212126056503
  • Kelly L, Dummett S, Dawson J, Fitzpatrick R, Jenkinson C, Morley D. Generating items for the Oxford Participation and Activities Questionnaire (Ox-PAQ). Qual Life Res. 2014;23(Suppl 1):81–82.
  • Morley D, Dummett S, Kelly L, Dawson J, Fitzpatrick R, Jenkinson C. Pretesting the Oxford Participation and Activities Questionnaire: results from an expert review. Mov Disord. 2015;30(Suppl 1):S419.
  • Morley D, Dummett S, Kelly L, Dawson J, Fitzpatrick R, Jenkinson C. Validation of the Oxford Participation and Activities Questionnaire. Patient Relat Outcome Meas. 2016;7:73–80. doi:10.2147/PROM.S9682227366108
  • Kelly L, Dummett S, Dawson J, et al. Pretesting an e-based version of the Oxford Participation and Activities Questionnaire (Ox-PAQ). Value Health. 2016;19:A485. doi:10.1016/j.jval.2016.09.804
  • Morley D, Dummett S, Kelly L, Dawson J, Fitzpatrick R, Jenkinson C. Ox-PAQ User Manual. Oxford: Health Services Research Unit; 2016.
  • Food and Drug Administration, Department of Health and Human Sciences. Guidance to Industry. Patient Reported Outcome Measures. Use in Medical Product Development to Support Labelling Claims. Silver Spring, MD: Food and Drug Administration; 2009.
  • European Medicines Agency (EMA). Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. EMEA/CHMP/EWP139391/2004. 2004.
  • Muhlan H, Bullinger M, Power M, Schmidt S. Short forms of subjective quality of life assessments from cross-cultural studies for use in surveys with different populations. Clinical Psychol Psychother. 2008;15:142–153. doi:10.1002/cpp.573
  • Ware J, Kosinski M, Keller SD. A 12 item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–233.8628042
  • Jones G, Jenkinson C, Kennedy S, Development of the short form endometriosis health profile questionnaire: the EHP-5. Qual Life Res. 2004;13:705–713. doi:10.1023/B:QURE.0000021316.79349.af15130032
  • Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–1736. doi:10.1007/s11136-011-9903-x21479777
  • Qualtrics, 2005. Copyright Year: 2017. Provo, Utah, USA.
  • Bartlett MS. Tests of significance in factor analysis. Br J Math Stat Psychol. 1950;3(2):77–85. doi:10.1111/j.2044-8317.1950.tb00285.x
  • Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297–334. doi:10.1007/BF02310555
  • Janssen MF, Pickard AS, Golicki D, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22(7):1717–1727. doi:10.1007/s11136-012-0169-823184421
  • Keeley T, Al-Janabi H, Lorgelly P, Coast J. A qualitative assessment of the content validity of the ICECAP-A and EQ-5D-5L and their appropriateness for use in health research. PLoS One. 2013;8(12):e85287. doi:10.1371/journal.pone.008528724367708
  • Kim SH, Kim HJ, Lee SI, Jo MW. Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Qual Life Res. 2012;21(6):1065–1073. doi:10.1007/s11136-011-0018-121947656
  • Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res. 1995;4:241–248.7613534
  • Jenkinson C, Fitzpatrick R, Peto V, Dummett S, Kelly L, Morley D. PDQ User Manual. 4th ed. Oxford: Health Services Research Unit; 2018.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.